EUVIMEDEUVIMED entdecken
Open Access

Mucinous Degeneration on MRI After Neoadjuvant Therapy in Patients With Rectal Adenocarcinoma: Frequency and Association With Clinical Outcomes

Joao Miranda, Paulo Victor Alves Pinto, Fernanda Kinochita, Camila Marchiolli Garcia, Maria El Homsi, Camila Vilela de Oliveira, Rafael Vaz Pandini, Caio Sergio Rizkallah Nahas, Sergio C Nahas, Marc J Gollub, Natally Horvat

American Journal of Roentgenology · 2023

DOI: 10.2214/ajr.23.29002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Roentgenology, 2023. Verfasst von Joao Miranda und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Sao Paulo, Sao Paulo, Brazil. Hauptthemen laut MEDLINE: Adenocarcinoma, Mucinous, Rectal Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND. Patients with nonmucinous rectal adenocarcinoma may develop mucinous changes after neoadjuvant chemoradiotherapy, which are described as mucinous degeneration. The finding's significance in earlier studies has varied. OBJECTIVE. The purpose of this study was to assess the frequency of mucinous degeneration on MRI after neoadjuvant therapy for rectal adenocarcinoma and to compare outcomes among patients with nonmucinous tumor, mucinous tumor, and mucinous degeneration on MRI. METHODS. This retrospective study included 201 patients (83 women, 118 men; mean age, 61.8 ± 2.2 [SD] years) with rectal adenocarcinoma who underwent neoadjuvant chemoradiotherapy followed by total mesorectal excision from October 2011 to November 2015, underwent baseline and restaging rectal MRI examinations, and had at least 2 years of follow-up. Two radiologists independently evaluated MRI examinations for mucin content, which was defined as T2 hyperintensity in the tumor or tumor bed, and resolved differences by consensus. Patients were classified into three groups on the basis of mucin status: those with nonmucinous tumor (≤ 50% mucin content on baseline and restaging examinations), those with mucinous tumor (> 50% mucin content on baseline and restaging examinations), and those with mucinous degeneration (≤ 50% mucin content on baseline examination and > 50% content on restaging examination). The three groups were compared. RESULTS. Interreader agreement for mucin content, expressed as a kappa coefficient, was 0.893 on baseline MRI and 0.890 on restaging MRI. Of the 201 patients, 156 (77.6%) had nonmucinous tumor, 34 (16.9%) had mucinous tumor, and 11 (5.5%) had mucinous degeneration. Mucin status was not significantly associated with complete pathologic response (p = .41) or local or distant recurrence (both p > .05). The death rate during follow-up was not significantly different (p = .21) between patients with nonmucinous tumor (23.1%), those with mucinous tumor (29.4%), and those with mucinous degeneration (9.1%). In adjusted Cox regression analysis, with mucinous degeneration used as reference, the HR for the overall survival rate for the mucinous tumor group was 4.7 (95% CI, 0.6-38.3; p = .14), and that for the nonmucinous tumor group was 8.0 (95% CI, 0.9-59.9; p = .06). On histopathologic assessment, all 11 patients with mucinous degeneration showed acellular mucin, yet 10 of 11 patients showed viable tumor (i.e., in nonmucinous portions of the tumors). CONCLUSION. Mucinous degeneration on MRI is not significantly associated with pathologic complete response, recurrence, or survival. CLINICAL IMPACT. Mucinous degeneration on MRI is uncommon and should not be deemed an indicator of pathologic complete response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma, MucinousRectal NeoplasmsMaleHumansFemaleMiddle AgedNeoadjuvant TherapyTreatment OutcomeRetrospective StudiesChemoradiotherapyMagnetic Resonance ImagingMucinsNeoplasm Staging

Stichwörter der Autor:innen

MRIrectal cancersurvival

Substanzen

Mucins

Autor:innen und Institutionen

  • Department of Radiology, University of Sao Paulo, Sao Paulo, Brazil.
  • Medical School, University of Sao Paulo, Sao Paulo, Brazil.
  • Department of Pathology, University of Sao Paulo, Sao Paulo, Brazil.
  • Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 29, New York, NY 10065.
  • Department of Surgery, University of Sao Paulo, Sao Paulo, Brazil.

Förderung

  • NCI NIH HHS

Zitieren

APA

Miranda, J., Pinto, P. V. A., Kinochita, F., Garcia, C. M., El Homsi, M., Vilela de Oliveira, C., Pandini, R. V., Nahas, C. S. R., Nahas, S. C., Gollub, M. J., & Horvat, N. (2023). Mucinous Degeneration on MRI After Neoadjuvant Therapy in Patients With Rectal Adenocarcinoma: Frequency and Association With Clinical Outcomes. American Journal of Roentgenology. https://doi.org/10.2214/ajr.23.29002

Vancouver

Miranda J, Pinto PVA, Kinochita F, Garcia CM, El Homsi M, Vilela de Oliveira C, et al. Mucinous Degeneration on MRI After Neoadjuvant Therapy in Patients With Rectal Adenocarcinoma: Frequency and Association With Clinical Outcomes. American Journal of Roentgenology. 2023. doi:10.2214/ajr.23.29002

BibTeX
@article{Miranda2023,
  author = {Miranda, Joao and Pinto, Paulo Victor Alves and Kinochita, Fernanda and Garcia, Camila Marchiolli and El Homsi, Maria and Vilela de Oliveira, Camila and Pandini, Rafael Vaz and Nahas, Caio Sergio Rizkallah and Nahas, Sergio C and Gollub, Marc J and Horvat, Natally},
  title = {Mucinous Degeneration on MRI After Neoadjuvant Therapy in Patients With Rectal Adenocarcinoma: Frequency and Association With Clinical Outcomes},
  journal = {American Journal of Roentgenology},
  year = {2023},
  doi = {10.2214/ajr.23.29002}
}
Kostenlos starten →